Search results
Results from the WOW.Com Content Network
This "formally initiates the litigation process under the Hatch-Waxman Act and triggers a 30-month stay of any potential FDA approval for Sun Pharma's ANDA," Mayne Pharma said in a statement.
Sun Pharmaceutical Industries Ltd. was established by Dilip Shanghvi in 1983 in Calcutta, West Bengal with five psychiatry products and a two-person marketing team. Today it is ranked number one in share of prescriptions with 12 classes of doctors in India and a market leader in Psychiatry, Neurology, Cardiology, Orthopaedics, Gastroenterology, Nephrology, Diabetology, Dermatology, Urology ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
This is an accepted version of this page This is the latest accepted revision, reviewed on 15 November 2024. Indian Businessman Dilip Shanghvi Born (1955-10-01) 1 October 1955 (age 69) Amreli, Gujarat, India Alma mater Bhawanipur Education Society College, University of Calcutta Occupation(s) Founder and MD of Sun Pharmaceuticals Spouse Vibha Shanghvi Children 2 Dilip Shanghvi (born 1 October ...
AOL latest headlines, entertainment, sports, articles for business, health and world news.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
DUSA Pharmaceuticals, Inc., owned by Sun Pharma, is a pharmaceutical company with dermatology products, including Levulan and Nicomide. In the first quarter of 2006, DUSA Pharmaceuticals obtained Sirius Laboratories in a merger estimated to be worth 30 million dollars.
Sun Pharma and Taro Announce Termination of Proposed Transaction HAWTHORNE, N.Y. & MUMBAI, India--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYS: TARO) ("Taro") and Sun Pharmaceutical ...